494
Participants
Start Date
May 7, 2020
Primary Completion Date
October 2, 2023
Study Completion Date
June 19, 2026
Belantamab mafodotin
Humanized anti-B-cell maturation antigen (BCMA) antibody/drug conjugate
Daratumumab
Anti-cluster of differentiation 38 \[CD-38\] monoclonal antibody
Bortezomib
Proteasome Inhibitor
Dexamethasone
Synthetic glucocorticoid with anti-tumor activity
GSK Investigational Site, Brussels
GSK Investigational Site, Brussels
GSK Investigational Site, Takapuna Auckland
GSK Investigational Site, Camperdown
GSK Investigational Site, St Leonards
GSK Investigational Site, Liverpool
GSK Investigational Site, Waratah
GSK Investigational Site, Wollongong
GSK Investigational Site, Melbourne
GSK Investigational Site, Heidelberg
GSK Investigational Site, Box Hill
GSK Investigational Site, Herston
GSK Investigational Site, Benowa
GSK Investigational Site, Ashford
GSK Investigational Site, Nedlands
GSK Investigational Site, Wellington
GSK Investigational Site, Murdoch
GSK Investigational Site, Christchurch
GSK Investigational Site, Roeselare
GSK Investigational Site, Ghent
GSK Investigational Site, Dunedin
GSK Investigational Site, Cáceres
GSK Investigational Site, Torino
GSK Investigational Site, Athens
GSK Investigational Site, Seongnam-si Gyeonggi-do
GSK Investigational Site, Caen
GSK Investigational Site, Milan
GSK Investigational Site, Roanoke
GSK Investigational Site, Bergamo
GSK Investigational Site, Brescia
GSK Investigational Site, Madrid
GSK Investigational Site, Pozuelo de AlarcOn Madr
GSK Investigational Site, MOstoles Madrid
GSK Investigational Site, Murcia
GSK Investigational Site, Krakow
GSK Investigational Site, Madrid
GSK Investigational Site, PamplonaNavarra
GSK Investigational Site, Gijón
GSK Investigational Site, Rennes
GSK Investigational Site, Salamanca
GSK Investigational Site, Bologna
GSK Investigational Site, Düsseldorf
GSK Investigational Site, Ulsan
GSK Investigational Site, Kfar Saba
GSK Investigational Site, Fairfield
GSK Investigational Site, Meldola FC
GSK Investigational Site, Ravenna
GSK Investigational Site, Pusan
GSK Investigational Site, Cologne
GSK Investigational Site, Tel Litwinsky
GSK Investigational Site, Siena
GSK Investigational Site, Thessaloniki
GSK Investigational Site, Tel Aviv
GSK Investigational Site, Kansas City
GSK Investigational Site, Paris
GSK Investigational Site, Tyler
GSK Investigational Site, Amiens
GSK Investigational Site, Denver
GSK Investigational Site, München
GSK Investigational Site, Yuma
GSK Investigational Site, Ulm
GSK Investigational Site, Jerusalem
GSK Investigational Site, Catania
GSK Investigational Site, Würzburg
GSK Investigational Site, Beijing
GSK Investigational Site, Beijing
GSK Investigational Site, Shenyang
GSK Investigational Site, Moscow
GSK Investigational Site, Changchun
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Nanjing
GSK Investigational Site, Suzhou
GSK Investigational Site, Jinan
GSK Investigational Site, Tianjin
GSK Investigational Site, Hangzhou
GSK Investigational Site, Saratov
GSK Investigational Site, Samara
GSK Investigational Site, Zhengzhou
GSK Investigational Site, Ufa
GSK Investigational Site, Guangzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Nizhny Novgorod
GSK Investigational Site, Novosibirsk
GSK Investigational Site, Rio de Janeiro
GSK Investigational Site, Florianópolis
GSK Investigational Site, Joinville
GSK Investigational Site, Natal
GSK Investigational Site, Porto Alegre
GSK Investigational Site, São Paulo
GSK Investigational Site, São Paulo
GSK Investigational Site, Edmonton
GSK Investigational Site, London
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Québec
GSK Investigational Site, Brno
GSK Investigational Site, Hradec Králové
GSK Investigational Site, Ostrava
GSK Investigational Site, Prague
GSK Investigational Site, Nice
GSK Investigational Site, Jena
GSK Investigational Site, Alexandroupoli
GSK Investigational Site, Roma
GSK Investigational Site, Aichi
GSK Investigational Site, Aichi
GSK Investigational Site, Aomori
GSK Investigational Site, Ehime
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Gifu
GSK Investigational Site, Gunma
GSK Investigational Site, Hyōgo
GSK Investigational Site, Kanagawa
GSK Investigational Site, Kanagawa
GSK Investigational Site, Kochi
GSK Investigational Site, Nagano
GSK Investigational Site, Okayama
GSK Investigational Site, Osaka
GSK Investigational Site, Osaka
GSK Investigational Site, Shizuoka
GSK Investigational Site, Dordrecht
GSK Investigational Site, Groningen
GSK Investigational Site, Chorzów
GSK Investigational Site, Lodz
GSK Investigational Site, Lublin
GSK Investigational Site, Lublin
GSK Investigational Site, Nowy Sącz
GSK Investigational Site, Poznan
GSK Investigational Site, Warsaw
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, L'Hospitalet de Llobrega
GSK Investigational Site, Bournemouth
GSK Investigational Site, Cardiff
GSK Investigational Site, Dundee
GSK Investigational Site, Leicester
GSK Investigational Site, London
GSK Investigational Site, Stoke-on-Trent
GSK Investigational Site, Sutton
Lead Sponsor
GlaxoSmithKline
INDUSTRY